Detection of clinically silent cerebral lesions after cardioversion Neurocognitive restriction.
Conditions
Interventions
Group 1: Patients with marcumar obtained before and after cardioversion an MRI for detecting silent cerebral lesions.
Group 2: Patients with new oral anticoagulants obtained before and after cardiover
Sponsors
Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Included are all patients (> 18 years), which undergo within the planned study period of 12 months a cardioversion of persistent atrial fibrillation and agree to participate in the study.
Exclusion criteria
Exclusion criteria: Not able to attend patients who have a contraindication to MRI or for hemodilution, in the present pregnancy or lack of Consent Declaration. Next patient are excluded, was where performed within 3 months before the planned cardioversion catheter ablation for the treatment of atrial fibrillation; also excluded are patients in which cardioversion has already been submitted in the last 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of clinical silent lesions after two weeks in MRI | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of any stroke (ischemic or hemorrhagic) and deaths from any cause within 30 days or within 12 months. | — |
Countries
Germany
Contacts
Public ContactBarbara Bellmann
Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin
Outcome results
None listed